Redefined Pharmacokinetic Parameters for Neonates with Hypoxic-Eschemic Encephalopathy Undergoing Therapeutic Hypothermia
Start Date
April 2026
Location
3rd floor - Library
Abstract
Pharmacokinetic modeling of morphine in neonates with hypoxic-ischemic encephalopathy (HIE) indicates that morphine clearance increases with gestational age, postnatal age, body weight, and temperature. This finding is especially relevant for dosing during therapeutic hypothermia, where current guidelines recommend a 50 µg/kg loading dose followed by a 5 µg/kg/hr maintenance infusion. These recommendations rely on standard allometric scaling, which fixes exponential values for volume of distribution at 1 and clearance at 0.75; however, this approach may not be appropriate for neonates. We found that higher exponential scaling values (1.77 for volume and 1.67 for clearance) more accurately predict plasma morphine concentrations in this population. Adjusting these values has important implications for neonatal drug dosing, particularly for medications with narrow therapeutic indices, where precise dosing is critical to maximize effectiveness while minimizing toxicity. This is consistent with other literature, showing that simulations using adjusted allometric factors better describe patient data associated with these treatments. Further research is needed to replicate these findings and determine more accurate and ethical dosing methods for neonatal patients.
Redefined Pharmacokinetic Parameters for Neonates with Hypoxic-Eschemic Encephalopathy Undergoing Therapeutic Hypothermia
3rd floor - Library
Pharmacokinetic modeling of morphine in neonates with hypoxic-ischemic encephalopathy (HIE) indicates that morphine clearance increases with gestational age, postnatal age, body weight, and temperature. This finding is especially relevant for dosing during therapeutic hypothermia, where current guidelines recommend a 50 µg/kg loading dose followed by a 5 µg/kg/hr maintenance infusion. These recommendations rely on standard allometric scaling, which fixes exponential values for volume of distribution at 1 and clearance at 0.75; however, this approach may not be appropriate for neonates. We found that higher exponential scaling values (1.77 for volume and 1.67 for clearance) more accurately predict plasma morphine concentrations in this population. Adjusting these values has important implications for neonatal drug dosing, particularly for medications with narrow therapeutic indices, where precise dosing is critical to maximize effectiveness while minimizing toxicity. This is consistent with other literature, showing that simulations using adjusted allometric factors better describe patient data associated with these treatments. Further research is needed to replicate these findings and determine more accurate and ethical dosing methods for neonatal patients.
